<DOC>
	<DOCNO>NCT00282581</DOCNO>
	<brief_summary>The purpose study assess safety immunogenicity two MVA smallpox vaccine injection healthy adult 18-35 year age HIV infection</brief_summary>
	<brief_title>Safety Study MVA Smallpox Vaccine HIV-positive Subjects Who Are Vaccinia Naive</brief_title>
	<detailed_description>This multi-center study 90 HIV-seropositive subject . There injection MVA smallpox vaccine placebo day 0 day 28 . Subjects enrol vaccinated two cohort accord CD4 cell count level number subject vaccinate . Excluding screening period , study duration approximately 56 day follow safety visit study day 148 telephone health status interview study day 208 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccinia</mesh_term>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults least 18 year old born 1971 never smallpox vaccination exposure vacciniacontaining product Subjects must test positive HIV infection Subjects must good general health except HIV infection , include AIDSdefining illness . Female Subjects must pregnant lactating , subject must agree practice birth control subject must clinically stable 6 month prior study enrollment . Subjects know suspected history immunodeficiency ( exception HIV infection ) Subjects history prior exposure vacciniacontaining product subject current radiation treatment use immunosuppressive antineoplastic drug ( exception ) Subjects concomitant illness associate impairment immunologic function . subject dementia Subjects malignancy . Subjects know history Cardiac disease , risk factor ischemic coronary disease , abnormalities Current past history eczema know allergy component MVA , include egg egg product , allergy blood product female must pregnant use approved contraceptive . Morbid obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>Smallpox</keyword>
	<keyword>MVA</keyword>
</DOC>